Bjartell, "Tumor markers in prostate cancer I: blood-based markers," Acta Oncologica, vol. 50, supplement 1, pp. 61-75, 2011.Shariat SF, Semjonow A, Lilja H, Savage C, Vickers AJ, Bjartell A. Tumor markers in prostate cancer I: blood-based markers. Acta Oncol. 2011; 50 Suppl ...
A tumor marker is a biomarker found in blood, urine or body tissues that can be elevated by the presence of one or more types of cancer. There are many different tumor markers, each indicative of a...
Blood-Based Tumor Markers for Prostate Cancer 来自 Springer 喜欢 0 阅读量: 26 作者:LC Wang,DS Scherr,SF Shariat 摘要: Although the wide availability of prostate-specific antigen (PSA) has revolutionized prostate cancer (PCa) screening, resulting in a decrease in PCa metastasis and death, the ...
CONTEXT: The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of the French Cancer Centers (FNCLCC), the 20 French Cancer Centers and specialists from French Public Universities, General Hospitals and Private Clinics. The main objecti...
1.Clinical evaluation of five tumor markers in peripheral blood from patients with gastric cancer;胃癌患者外周血中五种肿瘤标记物测定的临床意义 2.Clinical utility of serum tumor markers in mature cystic teratoma of the ovary and its malignant transformation;血清肿瘤标记物测定在卵巢成熟畸胎瘤及其恶变者...
Aiming to assess blood TMB (bTMB) prospectively, we conducted B-F1RST (NCT02848651), an open-label, phase 2 trial that evaluated bTMB as a predictive biomarker for first-line atezolizumab monotherapy in locally advanced or metastatic stage IIIB–IVB non-small cell lung cancer (n = 152)...
Tumor markers CA 125 and CA 19-9 are elevated in a variety of malignancies in adult patients, but only little is known of their biology during gestation or infancy. We have addressed the developmental pattern of these carbohydrate antigens in pediatric patients by measuring their serum levels in...
resembled VECs and showed a transitional state between a venous and lymphatic endothelial fate in terms of those specific markers (Fig.3j, k; Supplementary Fig.4a). Considering the elevated expression of mature lymphatic markers in veins ofFlcniΔECmice (Supplementary Fig.2m–o) we named this ...
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment Introduction Circulating tumor cells (CTCs) represent an independent predictor of outcome in patients with metastatic breast cancer (MBC). We assessed the ... M Giulian...
markers, including the VEGF receptor or c-met, can predict responses to sorafenib (reviewed in [17]), while tumor FGFR4 expression can predict responses to lenvatinib [18]. However, whether the immune-cell population can be a biomarker for MKIs still needs to be studied. Therefore, in the...